4//SEC Filing
Millar Kerri-Ann 4
Accession 0001209191-21-059698
CIK 0001645460other
Filed
Oct 4, 8:00 PM ET
Accepted
Oct 5, 7:21 PM ET
Size
15.0 KB
Accession
0001209191-21-059698
Insider Transaction Report
Form 4
Millar Kerri-Ann
CHIEF FINANCIAL OFFICER
Transactions
- Tax Payment
Common Stock
2021-08-23−1,961→ 10,472 total - Exercise/Conversion
Common Stock
2021-10-01$7.50/sh+1,251$9,383→ 11,723 total - Exercise/Conversion
Common Stock
2021-08-23+6,667→ 12,433 total - Sale
Common Stock
2021-10-01$14.21/sh−1,251$17,783→ 10,472 total - Exercise/Conversion
Restricted Stock Units
2021-08-23−6,667→ 6,667 total→ Common Stock (6,667 underlying) - Exercise/Conversion
Stock Option (right to buy)
2021-10-01−1,251→ 53,749 totalExercise: $7.50Exp: 2024-12-27→ Common Stock (1,251 underlying)
Footnotes (6)
- [F1]Represents shares of common stock received upon vesting of a restricted stock unit award.
- [F2]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2021.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.01 to $14.46, inclusive. The reporting person undertakes to provide to Cue Biopharma, Inc., any security holder of Cue Biopharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (3) to this Form 4.
- [F4]Each restricted stock unit award represents a contingent right to receive one share of common stock.
- [F5]Represents a restricted stock unit award granted on August 21, 2020. The restricted stock units vest in three equal annual installments beginning on August 21, 2020.
- [F6]The option vests in eight equal semi-annual installments beginning March 25, 2018.
Documents
Issuer
Cue Biopharma, Inc.
CIK 0001645460
Entity typeother
Related Parties
1- filerCIK 0001739126
Filing Metadata
- Form type
- 4
- Filed
- Oct 4, 8:00 PM ET
- Accepted
- Oct 5, 7:21 PM ET
- Size
- 15.0 KB